| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Muzzey Dale serves as a Chief Scientific Officer at MYGN. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $1.6M at current prices.
The biggest single holding is MYGN (~$1.6M) as Chief Scientific Officer. The recent filings there lean toward selling, a net 2,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2024 | MYGN Myriad Genetics Inc | Chief Scientific Officer | Sell | 2,100 | $26.17 | $54,961.20 | -1.9% | -41.6% | -70.8% |